geniposide has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, CY; Ma, ZG; Song, P; Tang, QZ; Yuan, YP; Zhang, X | 1 |
| Aburada, M; Ishizaki, J; Kojima, K; Miyamoto, K; Nagareda, Y; Sai, Y; Shimada, T; Watanabe, M | 1 |
2 other study(ies) available for geniposide and Obesity
| Article | Year |
|---|---|
Geniposide Protects against Obesity-Related Cardiac Injury through AMPK
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cardiomegaly; Diet, High-Fat; Heart; Inflammation; Iridoids; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Obesity; Signal Transduction; Sirtuin 1 | 2018 |
Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Fatty Acids, Nonesterified; Fatty Liver; Gardenia; Glucose Intolerance; Hep G2 Cells; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iridoids; Lipid Metabolism; Liver; Male; Metabolic Diseases; Metabolic Syndrome; Mice; Mice, Obese; Obesity; Phytotherapy; Plant Preparations | 2011 |